Increased susceptibility to Candida infection following cecal ligation and puncture

Biochemical and Biophysical Research Communications

Volumn 414, Issue 1, 2011, Pages 37-43

  Davis, Christopher G ^a   Chang, Kathy ^a   Osborne, Dale ^a   Walton, Andrew H ^a   Dunne, W Michael ^a   Muenzer, Jared T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida; Immune suppression; Secondary injury; Sepsis

Indexed keywords

CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CANDIDA ALBICANS; CANDIDIASIS; CECUM; CELL POPULATION; CONTROLLED STUDY; FATALITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; INJURY; INNATE IMMUNITY; KIDNEY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PUNCTURE; SPLEEN CELL; SURVIVAL RATE;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CECUM; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FLOW CYTOMETRY; IMMUNE TOLERANCE; IMMUNOCOMPROMISED HOST; LIGATION; MALE; MICE; MICE, INBRED C57BL; PUNCTURES; SEPSIS; SPLEEN;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; MURINAE; MUS;

EID: 80054064689     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.017     Document Type: Article

References (32)

1. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 2004, 39:309-317.
2. Klotz S.A., Chasin B.S., Powell B., et al. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 2007, 59:401-406.
3. Pfaller M.A., Diekema D.J. Epidemiology of invasive Candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007, 20:133-163.
4. Ashman R.B. Protective and pathologic immune responses against Candida albicans infection. Front. Biosci. 2008, 13:3334-3351.
5. Gudlaugasson O., Gillespie S., Lee K., et al. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 2003, 37:1172-1177.
6. Falagas M.E., Apostolou K.E., Pappas V.D. Attributable mortality of candidemia: a systematic review of matched cohort and case-controlled studies. Eur. J. Clin. Micrbiol. Infect. Dis. 2006, 25:419-425.
7. Enoch D.A., Ludlam H.A., Brown N.M. Invasive fungal infections: a review of epidemiology and management options. J. Med. Microbiol. 2006, 55:809-818.
8. Chandran J., Kuhn D.M., Mukherjee P.K., et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture and drug resistance. J. Bacteriol. 2001, 183:5385-5394.
9. Docke W.D., Randow F., Syrbe U., et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 1997, 3:678-681.
10. Heidecke C.D., Hensler T., Weighardt H., et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am. J. Surg. 1999, 178:288-292.
11. Rittirsch D., Flierl M.A., Ward P.A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 2008, 8:776-787.
12. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 2001, 166:6952-6963.
13. Pellegrini J.D., De A.K., Kodys K., et al. Relationship between T lymphocyte apoptosis and anergy following trauma. J. Surg. Res. 2000, 88:200-206.
14. Reddy R.C., Chen G.H., Tekchandani P.K., Standiford T.J. Sepsis-induced immunosuppression. Immunol. Res. 2001, 24:273-287.
15. Muenzer J.T., Davis C.G., Chang K., et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 2010, 78:1582-1592.
16. Baker C.C., Chaudry I.H., Gains H.O., Baue A.E. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983, 94:331-335.
17. Chaudry I.H., Wichterman K.A., Baue A.E. Effects of sepsis on tissue adenine nucleotide levels. Surgery 1979, 85:205-211.
18. M. Ariefdjohan, K. Queensland, L. Weitzel, et al. Elevated admission IL-10 level is associated with the development of sepsis in critically ill patients, in: Presented at Thirty Second Annual Conference on Shock, San Antonio, Texas, 2009.
19. Kalechman Y., Gafter U., Gal R., et al. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention. J. Immunol. 2002, 169:384-392.
20. Lederer J.A., Rodrick M.L., Mannick J.A. The effects of injury on the adaptive immune response. Shock 1999, 11:153-159.
21. Steinhauser M.L., Hogaboam C.M., Kunkel S.L., et al. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 1999, 162:392-399.
22. Romani L., Puccetti P., Mencacci A., et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 1994, 152:3514-3521.
23. Vazquez-Torres A., Jones-Carson J., Wagner R.D., et al. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 1999, 67:670-674.
24. Sieck T.G., Moors M.A., Buckley H.B., Blank K.J. Protection against murine disseminated Candidiasis mediated by a Candida albicans specific T-cell line. Infect. Immun. 1993, 61:3540-3543.
25. R.B. Ashman, C.S. Farah, S. Wanasaengsakul, et al., Innate versus adaptive immunity in Candida albicans infection, Immun. Cell Biol. 82 (2004) 196-204.
26. Netea N.G., Brown G.D., Kullberg B.J., Gow N.A. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Micrbiol. 2008, 6:67-78.
27. Mencacci A., Torosantucci A., Spaccapelo R., et al. Mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect. Immun. 1994, 62:5353-5360.
28. Qian Q., Jutila M.A., Van Rooijen N., Cutler J.E. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 1994, 152:5000-5008.
29. F.L. van de Veerdonk, B. Kullberg, M.G. Netea, Pathogenesis of invasive candidiasis, Infect. Dis. Crit. Care. (2010) 453-459.
30. MacCallum D.M., Castillo L., Brown A.J.P., et al. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PloS One 2009, 4:e6420.
31. MacCallum D.M. Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res. 2009, 9:1111-1122.
32. Muenzer J.T., Davis C.G., Dunne B.S., et al. Pneumonia after cecal ligation and puncture: a clinically relevant " two-hit" model of sepsis. Shock 2006, 26:565-570.